CRISPR-Cas enzymes: The toolkit revolutionizing diagnostics.
Biotechnol J
; 17(7): e2100304, 2022 Jul.
Article
in English
| MEDLINE | ID: covidwho-1400751
ABSTRACT
The programmable nature of sequence-specific targeting by CRISPR-Cas nucleases has revolutionized a wide range of genomic applications and is now emerging as a method for nucleic acid detection. We explore how the diversity of CRISPR systems and their fundamental mechanisms have given rise to a wave of new methods for target recognition and readout. These cross-disciplinary advances found at the intersection of CRISPR biology and engineering have led to the ability to rapidly generate solutions for emerging global challenges like the COVID-19 pandemic. We further discuss the advances and potential for CRISPR-based detection to have an impact across a continuum of diagnostic applications.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
CRISPR-Cas Systems
/
COVID-19
Type of study:
Diagnostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Biotechnol J
Journal subject:
Biotechnology
Year:
2022
Document Type:
Article
Affiliation country:
Biot.202100304
Similar
MEDLINE
...
LILACS
LIS